James Howard-Tripp
Chief Executive Officer at STAGEZERO LIFE SCIENCES LTD.
Net worth: 6 052 $ as of 2024-04-29
James Howard-Tripp active positions
| Companies | Position | Start | End |
|---|---|---|---|
| STAGEZERO LIFE SCIENCES LTD. | Chairman | 2013-07-18 | - |
| Chief Executive Officer | 2016-08-09 | - | |
| Public Communications Contact | 2001-12-31 | - | |
| Director/Board Member | 2001-12-31 | 2013-07-18 | |
| Independent Dir/Board Member | 2001-12-31 | 2013-07-18 | |
| Canadian Healthcare Licensing Association | Corporate Officer/Principal | 2009-08-19 | - |
| Chairman | - | 2009-08-19 | |
Innovative Diagnostic Laboratory LLP
 Innovative Diagnostic Laboratory LLP Medical/Nursing ServicesHealth Services Innovative Diagnostic Laboratory LLP offers risk assessment blood tests to find, understand, and treat cancer for the prevalent cancer types. Its products include colonsentry, earlyCDT-Lung, and prostate health index. The company is headquartered in Richmond, VA. | Chief Executive Officer | - | - |
GeneNews (USA), Inc.
 GeneNews (USA), Inc. Medical SpecialtiesHealth Technology GeneNews (USA), Inc. operates as a cancer diagnostics company. The firm focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management, with a primary focus on cancer-related indications. The company was incorporated on August 20, 2013 and is headquartered in Glen Allen, VA. | Director/Board Member | - | - |
| President | - | - |
Career history of James Howard-Tripp
Former positions of James Howard-Tripp
| Companies | Position | Start | End |
|---|---|---|---|
Labopharm, Inc.
 Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Director/Board Member | 2010-12-21 | 2011-03-13 |
| Chief Executive Officer | 1998-12-31 | 2011-03-13 | |
| President | 1998-12-31 | 2011-03-13 | |
| Allelix Biopharmaceuticals, Inc. | Chief Operating Officer | 1995-12-31 | - |
| Wyeth Ayerst Canada, Inc. | Corporate Officer/Principal | - | - |
| Allelix Neuroscience, Inc. | President | - | - |
| Paladin Labs Europe Ltd. | President | - | - |
Statistics
International
| Canada | 6 |
| United States | 4 |
| Ireland | 2 |
Operational
| President | 4 |
| Director/Board Member | 3 |
| Chief Executive Officer | 3 |
Sectoral
| Health Technology | 5 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| STAGEZERO LIFE SCIENCES LTD. | Health Technology |
| Private companies | 8 |
|---|---|
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Health Technology |
| Allelix Biopharmaceuticals, Inc. | Health Technology |
| Paladin Labs Europe Ltd. | |
| Canadian Healthcare Licensing Association | |
| Allelix Neuroscience, Inc. | |
| Wyeth Ayerst Canada, Inc. | |
Innovative Diagnostic Laboratory LLP
Innovative Diagnostic Laboratory LLP Medical/Nursing ServicesHealth Services Innovative Diagnostic Laboratory LLP offers risk assessment blood tests to find, understand, and treat cancer for the prevalent cancer types. Its products include colonsentry, earlyCDT-Lung, and prostate health index. The company is headquartered in Richmond, VA. | Health Services |
GeneNews (USA), Inc.
GeneNews (USA), Inc. Medical SpecialtiesHealth Technology GeneNews (USA), Inc. operates as a cancer diagnostics company. The firm focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management, with a primary focus on cancer-related indications. The company was incorporated on August 20, 2013 and is headquartered in Glen Allen, VA. | Health Technology |
- Stock Market
- Insiders
- James Howard-Tripp
- Experience